Format

Send to

Choose Destination
J Laryngol Otol. 2013 Feb;127(2):134-41. doi: 10.1017/S0022215112003118. Epub 2013 Jan 15.

Evaluation of antioxidant treatment in presbyacusis: prospective, placebo-controlled, double-blind, randomised trial.

Author information

1
Division of Otology and Neurotology, Department of Otolaryngology and Head and Neck Surgery, Federal University of São Paulo, Brazil.

Abstract

OBJECTIVE:

There are many well-known aetiological mechanisms of presbyacusis, and free radicals have been shown to play an important role. This study aimed to evaluate the effect of antioxidant agents on the hearing threshold of patients with presbyacusis.

METHODS:

One hundred and twenty individuals were divided into four groups and received one of the following treatment schemes: ginkgo biloba dry extract, α-lipoic acid plus vitamin C, papaverine chlorhydrate plus vitamin E, or placebo. All participants were evaluated at recruitment and after six months, using pure tone audiometry (at isolated and average frequencies), speech recognition threshold and percentage index of speech recognition.

RESULTS:

The various treatments had no effect on any of the evaluated measures of hearing, either between groups or over time.

CONCLUSION:

There was no statistically significant change in the hearing threshold after treatment with any of the tested drugs, during the study period.

PMID:
23318104
DOI:
10.1017/S0022215112003118
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Cambridge University Press
Loading ...
Support Center